Lectuure XXVVII

References:

Diabetes

1. Mishra et al. Diabetes and Nanomaterials. Digest Journal of Nanomaterials and Biostructures. 2008;3:109 – 113.

2. Cash H.J and Clark H.A,(2006).Nanosensors and nanomaterials for monitoring glucose in diabetes.Trends in Molecular Medicine.2006:Vol.16

3. Cavalcanti A et al. Medical nanorobotics for diabetes control. Nanomedicine:NBM. 2008;4:127-138.

4. Yin Yashu et al. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. Journal of Controlled Release. 2006;116:337 – 345.

5. Arya AK et al. Application of nanotechnology in diabetes. Digest Journal of Nanomaterials and Biostructures. 2008;3:221-225.

Hypertension

6. Mosgoeller W et al. Chapter Seventeen – Nanoparticle-mediated treatment of pulmonary arterial Hypertension. Methods of enzymology. 2012;508:325 – 354.

7. Libby P et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Saunders Elsevier. 2007;8:chap 41.

8. Wehling Martin. Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control. Clinical Therapeutics. 2004;26:A21 – A27.

9. Chen L et al. Nanoparticle-mediated delivery of angiotensin II receptor antagonist-induced pulmonary arterial hypertension in rats. International Journal of Cardiology. 2009;137:S145

10. Kimura S et al. Nanoparticle-Mediated Delivery of Nuclear Factor κB Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension. Hypertension – Journal of American Heart Association. 2009;53: 877 – 883.

11. Ankola DD et al. Development of potent oral nanoparticulate formulation of coenzyme Q10or treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/ theraphy?. European Journal of Pharmaceutics and Biopharmaceutics. 2007;67:361–369.

Cardiovascular Diseases

12. Winter PM et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 2003; 63(18):5838 – 5843.

13. Jaiswal JK et al. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biology. 2004; 14(9):497 – 504.

14. Gao X et al. Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol. 2003; 21(9):371 – 373.

15. Suzuki M et al. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J. Biomed. Mater. Res. 1998; 42:112 – 116.

16. Freitas RA et al. Exploratory design in medical nanotechnology: a mechanical artificial red cell. Artificial Cells, Blood Substitutes, and Immobil. Biotech. 1998; 26:411 – 430.

Asthma

17. Park et al. Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles. Int J Nanomedicine. 2010;5:505-515.

18. Da Silva AL et al. Nanoparticle based therapy for respiratory diseases. Annals of the Brazilian Academy of Sciences. 2013;85:137-146.

19. Oyarzun Ampuero FA et al. A potential nanomedicine consisting of heparin-loaded polysaccharide nanocarriers for the treatment of asthma. Macromolecular biosciene. 2011;12:176-183.